 HEIDELBERG, Germany, March 24, 2022 GLOBE NEWSWIRE -- Affimed N.V. Nasdaq: AFMD, a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release full year 2021 results and corporate update on Thursday, March 31, 2022. The Company will host a conference call at 8:30 a.m. Eastern Daylight Time. 